05:34 PM EDT, 08/19/2025 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on August 15, 2025, sold 6,979 shares in Alnylam Pharmaceuticals ( ALNY ) for $3,163,346. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 56,628 common shares of the company, with 56,221 shares held directly and 407 controlled indirectly. SEC Filing:...

05:37 PM EDT, 08/19/2025 (MT Newswires) -- Nicole Miller, Chief Legal Officer, on August 15, 2025, sold 25,154 shares in Legalzoom.com ( LZ ) for $272,166. Following the Form 4 filing with the SEC, Miller has control over a total of 960,032 common shares of the company, with 960,032 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1286139/000128613925000093/xslF345X05/wk-form4_1755639276.xml ...

05:34 PM EDT, 08/19/2025 (MT Newswires) -- Jeffrey V. Poulton, Executive Vice President, Chief Financial Officer, on August 15, 2025, sold 2,274 shares in Alnylam Pharmaceuticals ( ALNY ) for $1,030,727. Following the Form 4 filing with the SEC, Poulton has control over a total of 50,178 common shares of the company, with 50,121 shares held directly and 57 controlled...

05:36 PM EDT, 08/19/2025 (MT Newswires) -- Kevin Joseph Fitzgerald, Chief Scientific Officer, Executive Vice President, and Head of Research, on August 15, 2025, sold 1,396 shares in Alnylam Pharmaceuticals ( ALNY ) for $632,759. Following the Form 4 filing with the SEC, Fitzgerald has control over a total of 23,256 common shares of the company, with 22,719 shares held...